Views & Analysis Health data security: report’s implications for pharma Data security issues that could have an impact on the pharma industry.
Views & Analysis Healthcare’s hype cycle: which technologies will stay the co... Where should pharma invest to remain at the forefront of healthcare?
Views & Analysis Better clinical trial management Streamlining processes can improve clinical trial management, in terms of speed, quality and better collaboration.
Views & Analysis The evolving role of clinical trial data sharing Clinical trial data sharing has massive potential for catalysing scientific innovation.
Views & Analysis Healthcare evidence development: guilty until proven innocen... Pharma must prepare its case meticulously to support its new drug applications.
Views & Analysis Better customer engagement: Is your data letting you down? The pressure is on for better quality, more granular customer data.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
